Akèy › Blesi ren egi
Etid klinik pou Blesi ren egi ap rekrite nan Etazini
49 etid pou Blesi ren egi ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Cincinnati, OH8 etid
- Birmingham, AL8 etid
- Dallas, TX7 etid
- Durham, NC7 etid
- Baltimore, MD7 etid
- Ann Arbor, MI7 etid
- San Francisco, CA7 etid
- New York City, NY6 etid
- Cleveland, OH6 etid
- Boston, MA5 etid
- Pittsburgh, PA5 etid
- Houston, TX5 etid
- Atlanta, GA5 etid
- Detroit, MI5 etid
- Charleston, SC5 etid
- Rochester, MN4 etid
- Chicago, IL4 etid
- Nashville, TN4 etid
- New Haven, CT3 etid
- Seattle, WA3 etid
- Davie, FL3 etid
- Philadelphia, PA3 etid
- Washington, DC3 etid
- Winston-Salem, NC3 etid
- Louisville, KY3 etid
- The Bronx, NY3 etid
- Los Angeles, CA3 etid
- Columbus, OH3 etid
- Salt Lake City, UT3 etid
Pa eta
- Alabama8 etid
- Arizona3 etid
- Colorado4 etid
- Connecticut3 etid
- Florid8 etid
- Georgia5 etid
- Illinois4 etid
- Kalifòni12 etid
- Kentucky4 etid
- Maryland8 etid
- Massachusetts5 etid
- Michigan10 etid
- Minnesota5 etid
- New York8 etid
- North Carolina9 etid
- Ohio11 etid
- Pennsylvania8 etid
- South Carolina5 etid
- Tennessee5 etid
- Texas11 etid
- Utah3 etid
- Virginia5 etid
- Washington3 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Infliximab for Immune Checkpoint Inhibitor Associated AKI
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07683975A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05805709Nicotinamide Mononucleotide in Patients Undergoing Cardiac Surgery
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07013591Improving Preterm Kidney Outcomes With Caffeine
Ap rekriteFaz 2
12 Hours – 96 Hours · Tout sèks · Mizajou Sep 18, 2026 · NCT07262060Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07224243Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT05758077A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07734636A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07215702Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Aug 19, 2026 · NCT06937307The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07556107Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06699849A Study of Facilitators and Barriers to Improve Acute Kidney Injury in Children Through Mobile Health Intervention
Ap rekrite
Laj 1 a 18 · Tout sèks · Mizajou Aug 7, 2026 · NCT04403633Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT07016074Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05399537Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy
Ap rekriteFaz 2
Jiska laj 18 · Tout sèks · Mizajou Jul 24, 2026 · NCT07212595FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT07718464LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2026 · NCT06446739Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT07670520The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06802224Ultra-Low Contrast Angiography in AKI
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou May 18, 2026 · NCT05906758Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
Ap rekrite
9 Months – 21 Years · Tout sèks · Mizajou May 18, 2026 · NCT05219110QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
Ap rekriteEtid obsèvasyon
Jiska laj 22 · Tout sèks · Mizajou May 14, 2026 · NCT06517810Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 ak plis · Tout sèks · Mizajou May 4, 2026 · NCT06595420Acute Normovolemic Hemodilution on Urine Neutrophil Gelatinase-associated Lipocalin Levels
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou May 1, 2026 · NCT05349292Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT06840210Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.